$Coya Therapeutics(COYA.US)$ NEWS Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium Serum 4-HNE levels in ALS patients correlate with disease progression and survival, with higher levels indicating faster progression and shorter survival. The ROC analysis shows 100% sensitivity for a 21-month survival threshold, making it a potential biomarker for ALS. The presentation at the Johnson Center Symposium highlighted the predictive value of 4-HNE in as...
$Coya Therapeutics(COYA.US)$Coya Therapeutics Licenses IP Rights For Immune Modulatory Biologics In Combination With COYA 301 To Enhance Regulatory T Cells In Inflammatory Diseases Benzinga· 1 min ago
$Coya Therapeutics(COYA.US)$Coya Therapeutics Announces Pipeline Expansion Of COYA 302 To Include Frontotemporal Dementia and Parkinson's Disease Benzinga· 3 mins ago
$Coya Therapeutics(COYA.US)$Coya Therapeutics Reveals Successful Pre-IND And Type C Meetings With FDA To Advance Development Of COYA 302 For Treatment Of Amyotrophic Lateral Sclerosis (ALS) Benzinga· 5 mins ago
$Coya Therapeutics(COYA.US)$Dr. Reddy's To Make $7.5M Upfront Payment To Coya, $4.2M Payment Upon Acceptance Of IND Application, $4.2M Upon First Patient Dosing And Development And Regulatory Milestones Of Up To $40M; Coya Is Eligible For Up To $677.25M In Sales-Based Milestones
$Coya Therapeutics(COYA.US)$Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Coya Therapeutics股票討論區
NEWS
Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Serum 4-HNE levels in ALS patients correlate with disease progression and survival, with higher levels indicating faster progression and shorter survival. The ROC analysis shows 100% sensitivity for a 21-month survival threshold, making it a potential biomarker for ALS. The presentation at the Johnson Center Symposium highlighted the predictive value of 4-HNE in as...
Update
Benzinga· 1 min ago
Update
Benzinga· 3 mins ago
Update
Benzinga· 5 mins ago
Resume trade at 7:35 am est
More
Good pr follow with placement 🤣
Strong watch 7m float
Watching
暫無評論